Literature DB >> 23509949

Outcomes of liver resection in hepatocellular adenoma and focal nodular hyperplasia.

Matthanja Bieze1, Olivier R C Busch, Pieter J Tanis, Joanne Verheij, Saffire S K S Phoa, Dirk J Gouma, Thomas M van Gulik.   

Abstract

OBJECTIVES: The clinical management of hepatocellular adenoma (HCA) and focal nodular hyperplasia (FNH) is still subject to controversy, especially with respect to patient selection for surgery. The aim of this prospective cohort study was to assess the outcomes of surgical intervention.
METHODS: Between January 2008 and September 2012, patients diagnosed with FNH or HCA based on magnetic resonance imaging or computed tomography were enrolled in this prospective study. Resection was undertaken in patients with HCA of > 5 cm or symptomatic lesions. Lesion characteristics, extent of liver resection (minor: fewer than three segments; major: three or more segments), morbidity (by Dindo-Clavien class), mortality, postoperative length of stay and symptoms [McGill Pain Questionnaire, including a visual analogue scale (VAS)] were evaluated.
RESULTS: A total of 110 patients (106 female; median age: 39 years) were included; 51 patients had HCA and 59 had FNH. Of the 110 patients, 49 underwent resection (33 HCA patients; 16 FNH patients). Laparoscopic minor resection was performed in five HCA and five FNH patients; open minor resection was performed in 19 HCA and seven FNH patients, and open major resection was performed in nine HCA and four FNH patients. Severe postoperative complications were observed in four patients (Grade III, n = 3; Grade IV, n = 1). Median baseline scores on the VAS were 6 in FNH patients and 7 in HCA patients; the median VAS score after resection was 0 (P = 0.008).
CONCLUSIONS: If patients with HCA and FNH require surgery, limited resection can be carried out with low morbidity and without mortality. Patients with preoperative symptoms show a high rate of postoperative symptom relief.
© 2013 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2013        PMID: 23509949      PMCID: PMC3921009          DOI: 10.1111/hpb.12087

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  26 in total

1.  Indications and long-term outcome after elective surgery for hepatocellular adenoma.

Authors:  Aristotelis Perrakis; Volker Müller; Karin Oeckl; Boris Adamietz; Resit Demir; Werner Hohenberger; Sueleyman Yedibela
Journal:  Am Surg       Date:  2012-01       Impact factor: 0.688

Review 2.  Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update.

Authors:  P Bioulac-Sage; C Balabaud; P Bedossa; J Y Scoazec; L Chiche; A P Dhillon; L Ferrell; V Paradis; T Roskams; V Vilgrain; I R Wanless; J Zucman-Rossi
Journal:  J Hepatol       Date:  2007-01-02       Impact factor: 25.083

3.  Management of spontaneous haemorrhage and rupture of hepatocellular adenomas. A single centre experience.

Authors:  Deha Erdogan; Olivier R C Busch; Otto M van Delden; Fiebo J W Ten Kate; Dirk J Gouma; Thomas M van Gulik
Journal:  Liver Int       Date:  2006-05       Impact factor: 5.828

4.  Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium.

Authors:  Matthanja Bieze; Jacomina W van den Esschert; C Yung Nio; Joanne Verheij; Johannes B Reitsma; Valeska Terpstra; Thomas M van Gulik; Saffire S K S Phoa
Journal:  AJR Am J Roentgenol       Date:  2012-07       Impact factor: 3.959

5.  [The Dutch version of the McGill pain questionnaire: a reliable pain questionnaire].

Authors:  W A van der Kloot; R A Oostendorp; J van der Meij; J van den Heuvel
Journal:  Ned Tijdschr Geneeskd       Date:  1995-04-01

6.  A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas.

Authors:  Safi Dokmak; Valérie Paradis; Valérie Vilgrain; Alain Sauvanet; Olivier Farges; Dominique Valla; Pierre Bedossa; Jacques Belghiti
Journal:  Gastroenterology       Date:  2009-08-05       Impact factor: 22.682

7.  Hepatocellular adenoma: cost-effectiveness of different treatment strategies.

Authors:  Frederik Jan Fabian van der Sluis; Johanna L Bosch; Türkan Terkivatan; Robert A de Man; Jan N M Ijzermans; M G Myriam Hunink
Journal:  Radiology       Date:  2009-09       Impact factor: 11.105

8.  Massive hemorrhage and infarction complicating focal nodular hyperplasia of the liver.

Authors:  O F Bathe; C Mies; D Franceschi; J Casillas; A S Livingstone
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

9.  Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.

Authors:  Paulette Bioulac-Sage; Hervé Laumonier; Gabrielle Couchy; Brigitte Le Bail; Antonio Sa Cunha; Anne Rullier; Christophe Laurent; Jean-Frédéric Blanc; Gaelle Cubel; Hervé Trillaud; Jessica Zucman-Rossi; Charles Balabaud; Jean Saric
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

10.  Hepatocellular adenoma: an excellent indication for laparoscopic liver resection.

Authors:  Paulo Herman; Fabricio Ferreira Coelho; Marcos Vinicius Perini; Renato Micelli Lupinacci; Luiz Augusto Carneiro D'Albuquerque; Ivan Cecconello
Journal:  HPB (Oxford)       Date:  2012-03-28       Impact factor: 3.647

View more
  6 in total

1.  Short-term outcomes of laparoscopic vs. open liver resection for hepatocellular adenoma: a multicenter propensity score adjustment analysis by the AFC-HCA-2013 study group.

Authors:  Filippo Landi; Nicola De' Angelis; Olivier Scatton; Xavier Vidal; Ahmet Ayav; Fabrice Muscari; Safi Dokmak; Guido Torzilli; Nicolas Demartines; Olivier Soubrane; Daniel Cherqui; Jean Hardwigsen; Alexis Laurent
Journal:  Surg Endosc       Date:  2017-03-09       Impact factor: 4.584

2.  Long-term outcomes of resection in patients with symptomatic benign liver tumours.

Authors:  Belle V van Rosmalen; Matthanja Bieze; Marc G H Besselink; Pieter Tanis; Joanne Verheij; Saffire S K S Phoa; Olivier Busch; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2016-08-21       Impact factor: 3.647

Review 3.  Current Approaches in the Management of Hepatic Adenomas.

Authors:  Diamantis I Tsilimigras; Amir A Rahnemai-Azar; Ioannis Ntanasis-Stathopoulos; Maria Gavriatopoulou; Demetrios Moris; Eleftherios Spartalis; Jordan M Cloyd; Sharon M Weber; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2018-08-14       Impact factor: 3.452

4.  The value of liver resection for focal nodular hyperplasia: resection yes or no?

Authors:  Hans Michael Hau; Georgi Atanasov; Hans-Michael Tautenhahn; Rudolf Ascherl; Georg Wiltberger; Markus Bo Schoenberg; Mehmet Haluk Morgül; Dirk Uhlmann; Michael Moche; Jochen Fuchs; Moritz Schmelzle; Michael Bartels
Journal:  Eur J Med Res       Date:  2015-10-22       Impact factor: 2.175

Review 5.  Evolution and revolution of laparoscopic liver resection in Japan.

Authors:  Hironori Kaneko; Yuichiro Otsuka; Yoshihisa Kubota; Go Wakabayashi
Journal:  Ann Gastroenterol Surg       Date:  2017-04-25

6.  Indications for liver surgery in benign tumours.

Authors:  Margot Fodor; Florian Primavesi; Eva Braunwarth; Benno Cardini; Thomas Resch; Reto Bale; Daniel Putzer; Benjamin Henninger; Rupert Oberhuber; Manuel Maglione; Christian Margreiter; Stefan Schneeberger; Dietmar Öfner; Stefan Stättner
Journal:  Eur Surg       Date:  2018-05-22       Impact factor: 0.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.